Medical Equipment

Coronary Stents Market Outlook 2026–2035: Growth Drivers and Industry Forecast

February 3, 2026February 3, 2026 by Marketing Posting

Uncover key drivers, emerging technologies, and competitive movements shaping the workstation graphics processing unit (gpu) market from 2026–2035 with trusted insights from The Business Research Company

Across 2026–2030, what is the expected market valuation path of the Coronary Stents Market?

The coronary stents market size has experienced strong growth in recent years. It is projected to expand from $11.9 billion in 2025 to $12.9 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 8.3%. This historical growth can be attributed to a rising prevalence of coronary artery disease, an increasing number of percutaneous coronary intervention procedures, advancements in stent coating technologies, the expansion of interventional cardiology services, and improved clinical outcomes from coronary stenting.

The coronary stents market is projected to experience robust expansion in the upcoming years, with its value anticipated to reach $17.76 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 8.3%. This anticipated growth during the forecast period can be attributed to several factors, including an aging demographic with elevated cardiovascular risks, a rising demand for less invasive cardiac procedures, the increasing integration of advanced stent technologies, a greater emphasis on sustained vessel recovery and improved patient results, and the broadening availability of cardiac care in developing regions. Key trends expected during this period involve the heightened adoption of drug-eluting and dual therapy stents, a growing preference for less invasive coronary interventions, increased efforts to mitigate the risks of restenosis and thrombosis, the wider application of bioresorbable and biodegradable stents, and a surging demand for innovative stent materials and designs.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=18325&type=smp

Which Drivers Are Supporting The Rise Of The Coronary Stents Market?

The increasing occurrence of cardiovascular diseases (CVDs) is anticipated to drive the expansion of the coronary stent market in the future. CVDs encompass various disorders affecting the heart and blood vessels, including conditions like coronary artery disease, heart failure, stroke, and hypertension. The rise in cardiovascular diseases is attributed to factors such as an aging population and a higher prevalence of risk factors, including obesity, diabetes, sedentary lifestyles, poor diet, and stress. A coronary stent is essential for cardiovascular diseases to open narrowed or blocked coronary arteries, thereby improving blood flow to the heart and reducing the risk of heart attacks. For instance, in October 2024, according to the Centers for Disease Control and Prevention, a US-based, government agency, in 2023, cardiovascular disease claimed 919,032 lives, accounting for approximately one in every three deaths. Consequently, the growing prevalence of cardiovascular diseases (CVDs) is propelling the growth of the coronary stent market.

What Segments Are Identified Within The Structure Of The Coronary Stents Market?

The coronary stents market covered in this report is segmented –

1) By Product Type: Dual Therapy Stents, Radioactive Stents, Thrombectomy Stents, Covered Stents, Bioresorbable Stents, Biodegradable Stents, Hybrid Stents, Drug-Eluting Stents, Bare Metal Stents

2) By Technology: Laser Cutting, 3D-Printed Stents, Microfabrication, Nanotechnology-Based Stents, Electropolishing, Others Technologies

3) By Raw Material: Cobalt-Chromium, Stainless Steel, Platinum–Chromium, Nickel–Titanium, Polymer

4) By Deployment: Self-Expandable Stents, Balloon-Expandable Stents

5) By End Uses: Hospitals And Ambulatory Surgical Centers, Specialty Clinics, Other End Uses

Subsegments:

1) By Dual Therapy Stents: Sirolimus-Eluting Dual Therapy Stents, Paclitaxel-Eluting Dual Therapy Stents, Everolimus-Eluting Dual Therapy Stents

2) By Radioactive Stents: Beta Radiation Stents, Gamma Radiation Stents, Other Radiation Stents

3) By Thrombectomy Stents: Manual Thrombectomy Stents, Mechanical Thrombectomy Stents, Hydrodynamic Thrombectomy Stents

4) By Covered Stents: PTFE-Covered Stents, ePTFE-Covered Stents, Polyurethane-Covered Stents, Other Covered Stents

5) By Bioresorbable Stents: Polymer-Based Bioresorbable Stents, Metal-Based Bioresorbable Stents, Ceramic-Based Bioresorbable Stents

6) By Biodegradable Stents: Polymeric Biodegradable Stents, Magnesium-Based Biodegradable Stents, Other Biodegradable Stents

7) By Hybrid Stents: Hybrid Drug-Eluting Stents, Hybrid Biodegradable Or Metal Stents, Other Hybrid Stents

8) By Drug-Eluting Stents: Sirolimus-Eluting Stents, Paclitaxel-Eluting Stents, Everolimus-Eluting Stents, Zotarolimus-Eluting Stents, Other Drug-Eluting Stents

9) By Bare Metal Stents: Stainless Steel Bare Metal Stents, Cobalt Chromium Bare Metal Stents, Other Bare Metal Stents

What Trends Are Reshaping The Dynamics Of The Coronary Stents Market?

Major companies in the coronary stent market are developing innovative products, such as drug-eluting stents, to reduce the frequency of repeat procedures compared to bare-metal stents. Drug-eluting stents are specialized coronary stents featuring a medication coating designed to prevent arteries from re-narrowing by gradually releasing drugs over time. For instance, in May 2024, Abbott, a US-based healthcare company, launched the XIENCE Sierra Everolimus (drug) Eluting Coronary Stent System in India. The XIENCE Sierra stent is notable for its enhanced design, new delivery system, and unique size options, specifically engineered to manage challenging cases. It retains the specialized coating that minimizes the risk of artery re-blockage, consistent with other XIENCE stents. This stent benefits from an exceptional safety record, evidenced by over 120 clinical trials involving more than 120,000 patients.

Which Key Market Players Are Investing In Expansion And Innovation Within The Coronary Stents Market?

Major companies operating in the coronary stents market are Abbott Laboratories, Medtronic plc, Boston Scientific Corporation, Terumo Corporation, BIOTRONIK SE & Co KG, B Braun Melsungen AG, Biosensors International Group Ltd, MicroPort Scientific Corporation, Lepu Medical Technology Beijing Co Ltd, Meril Life Sciences Pvt Ltd, Stentys SA, Alvimedica, Vascular Concepts, Balton Medical, Cardionovum, HEXACATH, Elixir Medical Corporation, Translumina GmbH, Relisys Medical Devices Ltd, REVA Medical Inc, Sahajanand Medical Technologies Pvt Ltd, Endocor GmbH, Eurocor Tech, Medinol, Q3 Medical Devices, S3V Vascular Technologies, InSitu Technologies, Minvasys

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/coronary-stents-global-market-report

Which Regions Are Poised For Strategic Growth In The Coronary Stents Market?

North America was the largest region in the coronary stents market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the coronary stents market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Coronary Stents Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=18325&type=smp

Browse Through More Reports Similar to the Global Coronary Stents Market 2026, By The Business Research Company

Atherectomy Devices Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/atherectomy-devices-global-market-report

Coronary Angiography Devices Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/coronary-angiography-devices-global-market-report

Biopsy Devices Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/biopsy-devices-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795